Tag

Nandini Piramal

1 article

Piramal Pharma Q2/H1 FY27 Revenue Up 28%

Revenue rose 28% YoY to ₹2,617 cr in Q2 and 23% YoY to ₹4,887 cr in H1 FY27. EBITDA jumped 72% YoY to ₹385 cr in Q2 and ₹669 cr in H1, lifting margins to 14.7% and 13.7%. CDMO added 22 customers, host